| Model Number |
FV439T |
| Medical Device Problem Code |
Infusion or Flow Problem (2964)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
11/09/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Manufacturing site evaluation: no product received to date.Should relevant additional information/investigation results become available, an additional medwatch report will be submitted.
|
| |
|
Event or Problem Description
|
|
It was reported that a progav shuntsystem (#fv439t) was implanted during a procedure performed on (b)(6) 2021 according to the complainant, the shunt showed an over-drainage.The patient underwent a revision procedure performed on (b)(6) 2023.The complainant device has not yet returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 66 y weight: 78 kgs height: 170 cm gender: female.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation: visual inspection: no significant deformations or damage of the valve were detected during the visual inspection, but the measurement of the plane parallelism has revealed with a value of - 0.032 mm [outside the tolerance of 0 ± 0.02 mm] a deformation.Permeability test: a permeability test has shown that the valve is permeable.Computer controlled test: to investigate the claim of over- drainage, the opening pressure is measured using a miethke computer controlled test bench which simulates a cerebrospinal fluid flow.The valve is tested in the horizontal position.The results show that the valve operates within the accepted tolerances in the horizontal position.Adjustment test: the progav was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Internal inspection : after dismantling of the valve, deposits were found.Result : based on our investigation results, we can determine a deformation and deposits.Both had no effect to the technical properties at the time of the investigation.The cause of the aforementioned functional impairment is not known to us at the time of the examination.Organic material in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
|
| |
|
Event or Problem Description
|
|
The sample was returned for investigation to the manufacturer on 01/25/2024.The release was submitted on 02/15/2024.
|
| |
|
Search Alerts/Recalls
|